1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ETV3 CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA TMEM136 CTRPv2 pan-cancer AAC -0.14 0.0002
mRNA SERPINI1 CTRPv2 pan-cancer AAC 0.13 0.0002
mRNA C1orf106 CTRPv2 pan-cancer AAC 0.15 0.0002
mRNA THEM4 CTRPv2 pan-cancer AAC 0.15 0.0002
mRNA IRS2 CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA TCEAL3 CTRPv2 pan-cancer AAC -0.15 0.0002
mRNA CARD6 CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA ZNF394 CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA IL6R CTRPv2 pan-cancer AAC 0.13 0.0002
Download CSV